AADR vs ARKG

Both AADR and ARKG are ETFs. AADR has a lower 5-year return than ARKG (2.63% vs 12.56%). AADR has a higher expense ratio than ARKG (1.1% vs 0.75%). Below is the comparison between AADR and ARKG.

Together with FinMasters
Stock Wars
Pick any two stocks and find out how much money each would've made you had you purchased them at the same time.
AADR ARKG
Security Type ETF ETF
Category Foreign Large Growth Health
Family AdvisorShares ARK
Net Assets $38.80M $2.25B
Expense Ratio 1.10% 0.75%
Management Style passive (index-based) active
Dividend Yield 3.28% 0.00%
Underlying Index -- --
YTD Return -25.54% -46.73%
1-Year Return -27.47% -56.65%
3-Year Return -0.90% 6.13%
5-Year Return 2.63% 12.56%
10-Year Return 5.50% 0.00%

AADR

AADR description

null

AADR performance & returns

YTD Return -25.54%
1-Month Return 3.83%
3-Month Return -4.32%
1-Year Return -27.47%
3-Year Return -0.90%
5-Year Return 2.63%
10-Year Return 5.50%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (42.18% of Total Assets)

Name Symbol % Assets
ASML Holding NV ADR ASML 5.52%
Danaos Corp DAC.AX 4.78%
BioNTech SE ADR BNTX.DE 4.57%
Tata Motors Ltd ADR TTM.BO 4.23%
LVMH Moet Hennessy Louis Vuitton SE ADR LVMUY.PA 4.16%
ICICI Bank Ltd ADR IBN.BO 4.01%
Himax Technologies Inc ADR HIMX 3.79%
Tenaris SA ADR TS.MI 3.77%
Sasol Ltd ADR SSL.JO 3.71%
Sibanye Stillwater Ltd ADR SBSW.JO 3.64%

AADR pros

None that we could think of.

AADR cons

None that we could think of.

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.

    ARKG

    ARKG description

    null

    ARKG performance & returns

    YTD Return -46.73%
    1-Month Return 1.46%
    3-Month Return -11.21%
    1-Year Return -56.65%
    3-Year Return 6.13%
    5-Year Return 12.56%
    10-Year Return 0.00%
    ARKG expense ratio is 0.75%.

    ARKG holdings

    Top 10 Holdings (42.38% of Total Assets)

    Name Symbol % Assets
    Teladoc Health Inc TDOC 6.85%
    Exact Sciences Corp EXAS 5.00%
    Pacific Biosciences of California Inc PACB 4.79%
    CareDx Inc CDNA 4.25%
    Regeneron Pharmaceuticals Inc REGN 4.05%
    Vertex Pharmaceuticals Inc VRTX 3.64%
    Ionis Pharmaceuticals Inc IONS 3.62%
    Fate Therapeutics Inc FATE 3.58%
    Twist Bioscience Corp TWST 3.56%
    CRISPR Therapeutics AG CRSP 3.04%

    ARKG pros

    The following are ARKG strengths from our perspective:

    • ARKG 3-year return is 34.54%, which is higher than the 3-year return of the benchmark index (MSCI ACWI NR USD), 8.21%.
    • ARKG 5-year return is 24.54%, which is higher than the 5-year return of the benchmark index (MSCI ACWI NR USD), 10.45%.

    ARKG cons

    The following are ARKG weaknesses from our perspective:

    • ARKG net assets are $886.97 million. This fund is not a popular choice with retail investors.
    • ARKG expense ratio is 0.75%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?

    Other relevant ARKG comparisons

    You may also want to check out the following ARKG comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.
    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.